23.04
3.23%
-0.77
Precedente Chiudi:
$23.81
Aprire:
$24
Volume 24 ore:
391.43K
Capitalizzazione di mercato:
$1.08B
Reddito:
-
Utile/perdita netta:
$-71.58M
Rapporto P/E:
-18.56
EPS:
-1.2413
Flusso di cassa netto:
$-61.42M
1 W Prestazione:
-1.66%
1M Prestazione:
+33.18%
6M Prestazione:
+121.54%
1 anno Prestazione:
+15.20%
Enliven Therapeutics Inc Stock (ELVN) Company Profile
Nome
Enliven Therapeutics Inc
Settore
Industria
Telefono
720 647 8519
Indirizzo
6200 Lookout Road, Boulder
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-03-29 | Iniziato | Jefferies | Buy |
Enliven Therapeutics Inc Borsa (ELVN) Ultime notizie
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Expected to Post Q2 2024 Earnings of ($0.51) Per Share - MarketBeat
MarketBeat
Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Sells $27,675.00 in Stock - MarketBeat
MarketBeat
Enliven has cash runway into late 2026 – BizWest - BizWest
BizWest
Checking in on Enliven Therapeutics Inc (ELVN) after recent insiders movement – Knox Daily - Knox Daily
Knox Daily
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update - ForexTV.com
ForexTV.com
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update - GlobeNewswire
GlobeNewswire
Enliven Therapeutics Inc Azioni (ELVN) Dati Finanziari
Enliven Therapeutics Inc (ELVN) Reddito netto 2024
ELVN l'utile netto (TTM) è stato di -$71.58 milioni per il trimestre terminato il 2023-12-31, un -90.07% diminuire anno su anno.
Enliven Therapeutics Inc (ELVN) Flusso di cassa 2024
ELVN ha registrato un flusso di cassa disponibile (TTM) di -$61.42 milioni per il trimestre conclusosi con 2023-12-31, un -87.89% diminuire anno su anno.
Enliven Therapeutics Inc (ELVN) Utile per azione 2024
L'utile per azione (TTM) di ELVN è stato pari a -$1.7382 per il trimestre terminato il 2023-12-31, un -89.68% declino anno su anno.
Enliven Therapeutics Inc Azioni (ELVN) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Patel Anish | CHIEF OPERATING OFFICER |
May 14 '24 |
Sale |
25.00 |
1,107 |
27,675 |
0 |
Patel Anish | CHIEF OPERATING OFFICER |
May 09 '24 |
Option Exercise |
2.48 |
260 |
645 |
260 |
Patel Anish | CHIEF OPERATING OFFICER |
May 09 '24 |
Sale |
25.06 |
260 |
6,515 |
0 |
Patel Anish | CHIEF OPERATING OFFICER |
May 06 '24 |
Option Exercise |
2.48 |
4,875 |
12,090 |
4,875 |
Patel Anish | CHIEF OPERATING OFFICER |
May 06 '24 |
Sale |
22.72 |
4,875 |
110,769 |
0 |
Hohl Benjamin | CHIEF FINANCIAL OFFICER |
May 03 '24 |
Option Exercise |
2.48 |
1,000 |
2,480 |
1,000 |
Hohl Benjamin | CHIEF FINANCIAL OFFICER |
May 03 '24 |
Sale |
22.50 |
1,000 |
22,500 |
0 |
Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER |
Apr 29 '24 |
Option Exercise |
1.12 |
12,000 |
13,440 |
12,000 |
Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Apr 29 '24 |
Option Exercise |
2.48 |
3,250 |
8,060 |
3,250 |
Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER |
Apr 29 '24 |
Sale |
17.92 |
12,000 |
214,988 |
0 |
Capitalizzazione:
|
Volume (24 ore):